Healthcare ❯ Pharmaceuticals

Vaccines

COVID-19 Vaccines RSV Vaccine Covid-19 HPV Vaccine Covid-19 Vaccine COVID-19 Vaccine Sales Decline Covid-19 Vaccines Gardasil Mpox Vaccine COVID-19 Injectable Treatments AstraZeneca Covid Vaccine Covid Vaccine Vaccine Efficacy Combination Vaccines Safety HPV Vaccines Flu Vaccination Safety Data Specific Vaccines CSL's Seqirus

Pfizer’s Updated COVID-19 Vaccine Shows Strong Phase 3 Immune Response for 2025–2026 Formula

Analysts say the immune response results strengthen the case for FDA clearance, with a decision not yet announced.

CSL to Cut Up to 3,000 Jobs, Spin Off Seqirus in Sweeping Overhaul

Cofepris Authorizes Bi-Monthly Injectable PrEP in Mexico

GSK Secures $370 Million After CureVac US Patent Settlement

Merck Launches $3 Billion Cost-Optimization Program Following Q2 Revenue Miss

House Judiciary Committee Subpoenas Pfizer Scientist Over 2020 Vaccine Timing Allegations

Merck Stock Declines After Weak 2025 Guidance Despite Strong Q4 Results

Merck Cuts 2025 Revenue Forecast After Halting Gardasil Shipments to China

Moderna Cuts 2025 Revenue Forecast by $1 Billion, Shares Drop Over 20%

Novavax Shares Fall as Revenue Forecast Slashed Again

Moderna Reports Unexpected Profit on Strong COVID Vaccine Sales

GSK Faces Revenue Decline Amid Vaccine Sales Slump

Novavax Lowers 2024 Revenue Forecast, Reduces European Operations

CDC Updates RSV Vaccine Guidance for Older Adults

FDA Approves Moderna's mRNA RSV Vaccine for Older Adults

Sanofi and Novavax Forge Major Alliance, Boosting Novavax's Market Position

Moderna Suspends Construction of Vaccine Plant in Kenya Due to Low Demand